OMERS ADMINISTRATION Corp increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 9.0% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 25,671 shares of the medical equipment provider's stock after purchasing an additional 2,119 shares during the period. OMERS ADMINISTRATION Corp's holdings in Intuitive Surgical were worth $13,399,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors have also recently made changes to their positions in ISRG. Czech National Bank raised its holdings in shares of Intuitive Surgical by 6.9% during the fourth quarter. Czech National Bank now owns 77,227 shares of the medical equipment provider's stock worth $40,309,000 after purchasing an additional 4,970 shares during the last quarter. Fiduciary Alliance LLC raised its stake in shares of Intuitive Surgical by 33.7% during the 4th quarter. Fiduciary Alliance LLC now owns 12,497 shares of the medical equipment provider's stock valued at $6,523,000 after buying an additional 3,151 shares during the last quarter. Brookstone Capital Management raised its stake in shares of Intuitive Surgical by 25.4% during the 4th quarter. Brookstone Capital Management now owns 18,102 shares of the medical equipment provider's stock valued at $9,448,000 after buying an additional 3,663 shares during the last quarter. Capital Investment Advisors LLC lifted its holdings in shares of Intuitive Surgical by 15.6% in the 4th quarter. Capital Investment Advisors LLC now owns 899 shares of the medical equipment provider's stock valued at $469,000 after buying an additional 121 shares during the period. Finally, Kieckhefer Group LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth about $5,632,000. 83.64% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
ISRG has been the topic of a number of research analyst reports. Truist Financial dropped their price target on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research note on Wednesday, April 23rd. Jefferies Financial Group lifted their target price on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Barclays cut their price target on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research note on Thursday, April 24th. Raymond James raised their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an "outperform" rating in a report on Friday, January 24th. Finally, Evercore ISI reduced their price objective on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a research note on Wednesday, April 23rd. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $598.95.
Check Out Our Latest Analysis on Intuitive Surgical
Intuitive Surgical Price Performance
ISRG stock traded up $3.32 during trading hours on Friday, reaching $563.60. 1,422,176 shares of the stock were exchanged, compared to its average volume of 1,640,855. Intuitive Surgical, Inc. has a 12 month low of $393.98 and a 12 month high of $616.00. The firm's 50-day moving average is $503.82 and its 200-day moving average is $536.13. The company has a market cap of $202.00 billion, a price-to-earnings ratio of 87.93, a PEG ratio of 5.85 and a beta of 1.70.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The company had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. During the same period in the prior year, the firm earned $1.50 EPS. As a group, equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.
Insider Buying and Selling at Intuitive Surgical
In related news, EVP Robert Desantis sold 11,545 shares of the business's stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the transaction, the executive vice president now directly owns 5,224 shares in the company, valued at $2,607,925.28. The trade was a 68.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Jami K. Nachtsheim sold 2,400 shares of the company's stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the sale, the director now directly owns 6,371 shares of the company's stock, valued at approximately $3,312,920. This represents a 27.36% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 32,700 shares of company stock worth $16,865,621. Insiders own 0.70% of the company's stock.
Intuitive Surgical Company Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.